Medical Breakthroughs
CMS’s 10-Year VBC Plan: The AI Investment Mandate
The strategic investor in healthcare AI understands that true disruption isn’t born in a vacuum; it’s…
Medical Breakthroughs
Medical Breakthroughs
CMS TEAM Model: Investing in AI’s Value-Based Care Future
The landscape of healthcare investment is perpetually reshaped by regulatory shifts, and few entities wield as…
Medical Breakthroughs
Healthcare AI: Platform vs. Point Solution Investment Matrix
The strategic allocation of capital in the burgeoning healthcare AI sector demands a nuanced understanding of…
Medical Breakthroughs
VC Due Diligence: 12 Questions for Healthcare AI Investment
The healthcare AI investment landscape, while brimming with potential, presents a complex labyrinth for even the…
Medical Breakthroughs
Payer Policy Shift: Which AI Health Tools Will Survive?
The landscape for artificial intelligence in healthcare is undergoing a profound transformation, driven by a critical…
Medical Breakthroughs
VBC: The Billion-Dollar Tailwind for AI Health Investing
The healthcare landscape is undergoing a monumental shift, one that is poised to unlock unprecedented opportunities…
Medical Breakthroughs
ACO REACH to LEAD: AI Health Revenue Impact for Investors
The Centers for Medicare & Medicaid Services (CMS) continually refines its value-based care (VBC) models, a…
Medical Breakthroughs
AI Health Compliance: Real-Time Regulatory Scorecard for 30 Companies
Navigating the labyrinthine regulatory landscape of AI in healthcare is no longer a peripheral concern for…
Medical Breakthroughs
Regulatory Readiness: The AI Health Capital Magnet?
In the dynamic landscape of healthcare AI, investment decisions are increasingly complex, fraught with both immense…
Medical Breakthroughs
AI Health’s $35 Billion Mistake: The Unit Economics Framework Investors Need
The healthcare AI landscape has been a volatile terrain for investors, marked by both transformative potential…